Share
People experiencing Long COVID will benefit from a comprehensive package of new NIHR-funded research to help improve understanding of the condition, from diagnosis and treatment through to rehabilitation and recovery. 15 projects from across the UK have been awarded a total of £19.6 million to examine causes of Long COVID, trial drugs to tackle it, and investigate symptoms such as breathlessness and ‘brain fog’ that have become synonymous with the condition. Studies will also evaluate health services, such as Long COVID clinics, and explore ways patients can monitor the condition to optimise their recovery and return to work.
Health and Social Care Secretary, Sajid Javid, said, ‘Long COVID can have serious and debilitating long-term effects for thousands of people across the UK, which can make daily life extremely challenging. This new research is absolutely essential to improve diagnosis and treatments and will be life-changing for those who are battling long-term sy
New research into treatment and diagnosis of long COVID
15 new studies across the UK will expand research into long COVID to support thousands of vulnerable people, backed by nearly £20 million through the NIHR
From:
15 new studies across UK to expand research that will support thousands of vulnerable people
Nearly £20 million for research projects will help improve understanding of long COVID and identify effective treatments
Projects include the largest long COVID trial to date which will involve over 4,500 people
Thousands of people suffering with long COVID will benefit from new research programmes backed by £19.6 million to help better understand the condition, improve diagnosis and find new treatments.